Protherics enlists Ashurst on takeover

Ashurst is advising UK biotech company Protherics after it announced several takeover approaches from unnamed parties.

Corporate partners Andrew Edge and Michael Johns and IP partner Dominic Batchelor are advising.

Possible bidders include AstraZeneca, which has previously used ­Linklaters and Freshfields Bruckhaus Deringer, and biotech company BTG, usually advised by Allen & Overy.